PrecISE

PrecISE, the Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network, is a research study to understand how to treat different types of severe asthma, by using precision medicine. Precision medicine is an approach that targets treatments to defined subgroups of patients who share similar characteristics, like types of inflammation or presence of certain genetic variations.

We are looking for teenagers (ages 12 years and older) who have severe or exacerbation prone asthma. The primary objective of this study is to evaluate several interventions given to participants with severe asthma. Everyone in the study will receive one or more study medicines for their severe asthma, but please note that participants will not have to change their regular care or stop medicines that have been working to enroll. This study is sponsored by the U.S. National Heart, Lung, and Blood Institute (NHLBI).

Principal Investigator: Rajesh Kumar, MD

Interested in Participating? 

For more information about PrecISE, please contact Opinderjit Kaur at okaur@luriechildrens.org.